Inari Medical stock skyrocketed Monday afternoon and again Tuesday morning after a report that it was close to being acquired by Stryker proved to be true, with the companies announcing the deal after ...

Learn more about whether Glaukos Corporation or Inari Medical, Inc. is a better investment based on AAII's A+ Investor grades ...

Inari Medical, Inc. NARI is well-poised for growth on the back of a huge market opportunity for its products and its commitment to understanding the venous system. However, the company’s dependency on ...

Inari Medical Inc., one of Orange County’s fastest-growing medical device makers, is being acquired for $4.9 billion by global medical technology company Stryker Corp. Stryker on Jan. 6 announced an ...

Stryker reported goodwill and other impairments of $818 million related to the spine business in the fourth quarter.

Specialized in devices to treat venous thromboembolism, Inari's stock increased 56% over the past month in response to rumors of a possible merger. Warning! GuruFocus has detected 7 Warning Signs ...

Stryker has agreed to acquire medical technology maker Inari Medical NARI-0.15%decrease; red down pointing triangle in a deal worth $4.9 billion, the companies said Monday. The medical device ...

U.S. stock futures are little changed after indexes were mixed Monday; Nvidia stock adds to all-time high after CEO comments; ...

Inari jumped 21% in after hours trading. The medical devices firm will pay $80 a share in cash for Inari (NASDAQ:NARI), according to a statement on Monday. The deal represents a more than 60% ...

Stryker will acquire Inari in an all-cash deal for $80 per share, valuing it at roughly $4.9 billion. The deal for the vascular medical device maker was first reported by Reuters Monday afternoon ...

Stryker will purchase Inari's common stock for $80 per share. Inari Medical’s product portfolio includes medical devices that treat pulmonary embolism, deep vein thrombosis, in-stent thrombosis ...